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Summary
Background:  The  co-circulation  of  multiple  dengue  virus  serotypes  has  been  reported
in  many  parts  of  the  world,  including  India;  however,  concurrent  infection  with  more
than  one  serotype  of  dengue  virus  in  the  same  individual  is  rarely  documented.
Method:  An  outbreak  of  dengue  hemorrhagic  fever/dengue  shock  syndrome
(DHF/DSS)  occurred  in  and  around  Davangere,  Karnataka,  from  June  2011—March
2012.  This  is  the  ﬁrst  report  from  India  with  a  high  percentage  of  concurrent  infec-
tions  with  different  dengue  virus  serotypes  circulating  during  one  outbreak.  Acute
phase  sera  from  patients  were  tested  for  the  presence  of  dengue  virus  RNA  by
RT-PCR.
Results:  Of  the  72  samples  tested  for  dengue  virus  RNA,  42  (58.3%)  were  positive.
All  four  dengue  virus  serotypes  were  found  to  be  co-circulating  in  this  outbreak,  and
DENV-2  was  the  predominant  serotype.  In  addition,  concurrent  infection  with  more
than  one  dengue  virus  serotype  was  identiﬁed  in  18  (42.9%)  dengue  virus-positive
samples.
Conclusion:  Our  study  showed  that  serotype  DEN-2  was  dominant  in  the  positive
dengue  virus-infected  samples;  the  other  serotype  present  was  DEN-3.  This  is  the
ﬁrst  report  of  concurrent  infections  with  different  dengue  virus  serotypes  in  this
part  of  the  world.
©  2013  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Ltd.  All  rights  reserved.∗ Corresponding author. Tel.: +91 9964402525.
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aoexisting  infections  with  multiple  dengue  virus  se
ntroduction
engue  infections  are  a  signiﬁcant  cause  of  mor-
idity  and  mortality  and  lead  to  adverse  economic
ffects  in  many  developing  tropical  countries  [1].
he incidence  of  dengue  fever  is  on  the  rise  world-
ide, and  in  some  areas  of  Asia,  complications  from
he disease  are  a  leading  cause  of  serious  illness  and
eath in  children  [2,3].
Dengue illnesses  are  caused  by  four  serologically
elated viruses,  designated  as  DENV-1,  DENV-2,
ENV-3 and  DENV-4  [4,5]. Infection  with  any  one  of
hese serotypes  mostly  causes  a  mild,  self-limiting
ebrile illness  (classical  dengue  fever  (DF));  how-
ver, a  few  cases  develop  severe  life-threatening
engue hemorrhagic  fever  (DHF)  or  dengue  shock
yndrome  (DSS).  Clinical  observation  is  important
or the  diagnosis  of  DF  and  DHF,  and  laboratory
ests are  essential  for  conﬁrmation.  An  enzyme-
inked immunosorbent  assay  has  recently  been  used
n many  laboratories  [6]. Viral  isolation  is  a  deﬁni-
ive test,  but  it  is  time  consuming.  Instead  of
irus isolation,  reverse  transcription  polymerase
hain reaction  (RT-PCR)  has  been  widely  used  for
engue diagnosis.  It  has  been  reported  that  RT-
CR is  positive  in  serum  samples  collected  in  the
ebrile stage  of  primary  dengue  virus  infection
7—9].  In  recent  years,  the  co-circulation  of  mul-
iple  dengue  virus  serotypes  has  been  increasingly
eported with  concurrent  infections.  However,  the
ssociation  of  concurrent  infection  with  severe
orms of  the  disease  (DHF/DSS)  requires  further
tudy [10].
In this  study,  we  report  the  detection  of  dengue
irus RNA  by  RT-PCR  during  a  dengue  outbreak  that
ccurred  in  and  around  Davangere  district  from
une  2011—March  2012.
aterials and methods
wo  blood  samples  were  collected  from  72  patients
ith a  <7-day  history  of  fever  who  presented  to  out-
atient  departments  from  mid-June  2011—March
012. One  blood  sample  was  sent  on  ice  to  the
olecular laboratory  for  the  detection  of  dengue
iruses, the  NS1  antigen  and  IgM  and  IgG  antibod-
es. The  second  sample  was  used  for  a  complete
lood hemogram.  The  clinical  basis  for  diagnosing
atients with  dengue  virus  infection  was  based  on
he WHO  deﬁnitions.  Because  these  diagnostic  sam-
les were  received  during  an  outbreak,  no  prior
thical clearance  was  required.  However,  patient
nformation  was  de-linked  from  the  sample  infor-
ation  to  protect  patient  privacy.
T
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Viral  RNA  was  extracted  from  serum  samples
sing the  QIAamp  Viral  RNA  mini  kit  (Qiagen,
ermany) according  to  the  manufacturers’  instruc-
ions. Extracted  RNA  was  stored  at  −70 ◦C  or
mmediately used  for  RT-PCR.  RT  and  PCR  were
erformed in  one  tube  using  a  universal  primer
nd a one-step  RT  kit  (QIAGEN,  GmbH,  Hilden,
ermany); the  reaction  was  then  placed  in  a ther-
al cycler  (Eppendorf).  The  preliminary  product
as further  used  for  nested  PCR  in  another  reaction
ube [8]. Nested  PCR  was  performed  with  a  thermal
ycler.  The  secondary  PCR  product  was  subjected  to
garose gel  electrophoresis  using  a  2%  agarose  gel
Bangalore  Gene)  in  Tris—borate  buffer,  followed  by
taining with  ethidium  bromide  and  visualization  on
 UV  transilluminator  at  302  nm.
The NS1  antigen  and  IgM  and  IgG  antibodies  were
etected with  ICT.  The  test  kit  used  was  the  dengue
S1 antigen  and  antibody  Combi  Card  supplied  by
. Mitra  and  Co.  Pvt  Ltd.  (New  Delhi,  India)  [6].
tatistical analysis
ll  statistical  analyses  were  performed  using  SPSS
ersion 16  software.
esults
f  72  samples,  42  (58.3%)  tested  positive  for dengue
iral RNA  by  RT-PCR.  Twenty-four  cases  were
nfected with  a  single  DENV  serotype,  and  18  had
 concurrent  infection  with  two  DENV  serotypes.
f the  24  single-infection  cases,  13  (54.2%)  were
yped  as  DENV-2,  7  (29.2%)  as  DENV-3,  2  (8.3%)  as
ENV-1 and  2  (8.3%)  as  DENV-4.  DENV-2  dominated
he outbreak,  accounting  for  54.2%  of  the  positive
amples,  followed  by  DENV-3  (29.2%).  The  overall
revalence  of  concurrent  infections  was  42.9%.  Co-
nfection with  serotypes  DENV-2  and  DENV-3  was
ound to  account  for  66.7%  of  all  concurrent  infec-
ions. Other  combinations  included  the  following:
ENV-1 and  DENV-2  (3  of  18,  16.7%);  DENV-1  and
ENV-3  (2  of  18,  11.1%);  and  DENV-2  and  DENV-
 (1  of  18,  5.6%).  Thus,  DENV-2  and  DENV-3  were
he most  commonly  combined  serotypes  observed
uring the  outbreak.  Of  the  42  patients  in  whom
engue virus  RNA  was  detected,  25  were  male  and
7 were  female  (Table  1).  Forty-one  samples  were
rom the  pediatric  age  group  (<12  years  of  age),
nd one  sample  was  from  an  adult  (23  years  of  age).
he mean  age  of  patients  with  positive  samples  was
.9 ±  7.8  years.  The  maximum  number  of  dengue
irus-positive cases  occurred  in  patients  5—10  years
f age  (45.2%),  followed  by  those  >10  years  of  age
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Table  1  Age  and  sex  distribution  of  the  RT-PCR-
positive  dengue  cases.
Age  (years)  Sex  Total
Male  Female
<5  5  6  11
6—10  11  8  19
>10  9  03  12
Total  25  17  42
Table  2  Clinical  manifestations  of  patients  with
dengue  infection.
Clinical  features  Number  (%)
Fever  42  (100)
Retro-orbital  pain  25  (59.5)
Flushing  30  (71.4)
Rash  12  (28.6)
ARDS  13  (31.0)
Encephalopathy  05  (11.9)
Hepatomegaly  11  (26.2)
Splenomegaly  12  (28.6)
Ascites  05  (11.9)
Pleural  effusion  03  (7.1)
Cyanosis  01  (2.4)
Convulsion  02  (4.8)
Oliguria  01  (2.4)
Hypoglycemia  01  (2.4)
Abscess  01  (2.4)
Pneumonia  03  (7.1)
Table  4  Comparison  of  the  efﬁcacy  of  various
dengue-speciﬁc  parameters  in  RT-PCR-positive  cases.
Parameters  Total  %
NS1  37  88.1%
NS1  +  IgM  04  9.5%
IgM  01  2.4%
IgM  +  IgG 00  00
IgG  00  00
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Gum  bleeding 01  (2.4)
(28.6%)  and  <5  years  of  age  (26.2%).  The  clinical
features of  the  patients  in  whom  dengue  virus  RNA
was detected  are  summarized  in  Table  2.  Fever
was the  most  common  clinical  presentation  occur-
ring in  all  patients  on  presentation.  There  was
no speciﬁc  pattern  of  fever,  and  the  fever  ranged
from 38 ◦C  to  40 ◦C.  Other  common  clinical  fea-
tures included  retro-orbital  pain  (59.5%),  ﬂushing
(71.4%)  and  rashes  (28.6%).  ARDS  was  observed
in 31.0%  of  patients,  splenomegaly  in  28.6%,
ascites in  11.9%  and  encephalopathy  in  11.9%.  A
platelet count  <100,000  was  observed  in  37  (88.9%)
t
c
d
Table  3  Platelet  count  in  dengue  RT-PCR-positive  cases.
Age  (years)  Platelet  count  
<20,000  20,001—50,000  
<5  1  6  
6—10  5  9  
>10  0  5  
Total  6  20  Total 42  100%
atients,  a platelet  count  of  50,000—100,000  was
bserved  in  11  (26.2%)  patients,  a platelet  count  of
0,000—50,000  was  observed  in  20  (47.6%)  patients,
nd a platelet  count  <20,000  was  observed  in  6
14.3%) patients  (Table  3).  Per  the  classiﬁcation
ased on  the  WHO  deﬁnition  (28),  DF  was  observed
n 18  cases  with  a single-serotype  infection  and  5
ases with  concurrent  infections,  whereas  DHF  was
resent in  6  cases  with  a  single-serotype  infection
nd 11  cases  with  concurrent  infections.
Of the  42  samples  that  were  positive  by  RT-PCR,
7 (88.1%)  were  positive  for  NS1  antigen  only,  4
9.5%) were  positive  for  NS1  and  IgM,  and  1  (2.4%)
as positive  for  IgM  only  (Table  4).
iscussion
engue  is  a major  public  health  problem  in  Davan-
ere and  surrounding  districts  in  the  state  of
arnataka  in  south  India.  Over  the  last  5—6  years,
e have  observed  varied  clinical  manifestations
f dengue  that  differ  from  past  reports  from  this
egion  and  other  parts  of  the  country.  The  ﬁrst
engue epidemic  in  India  occurred  in  Kolkata  in
963—64 [11], and  since  that  time,  the  epidemi-
logy of  dengue  virus  has  been  evolving.  This  is
he ﬁrst  study  from  this  region  to  report  concurrent
nfections with  different  dengue  virus  serotypes.  In
his study,  we  report  a  high  percentage  (42.9%)  of
oncurrent  infections.
The  ﬁrst  case  of  concurrent  infections  with  2
engue  virus  serotypes  was  reported  in  Puerto  Rico
Total
50,001—1,00,000  >1,00,000
4  0  11
3  2  19
4  3  12
11  5  42
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Coexisting  infections  with  multiple  dengue  virus  se
n  1982  [10],  and  since  then,  other  countries  have
lso reported  the  occurrence  of  concurrent  infec-
ions  [12,13]  in  areas  where  multiple  dengue  virus
erotypes  co-circulate.  In  a  study  carried  out  in
elhi in  2006,  19%  of  the  reported  cases  were  con-
urrent  infections.  Previous  studies  with  a  lower
ercentage of  concurrent  infections  have  been
eported  in  Taiwan  (9.5%)  and  Indonesia  (11%)  and  in
exico, Puerto  Rico  and  Indonesia  together  (5.5%)
12,13].  DENV-1  and  DENV-3  were  identiﬁed  as  the
ost frequent  dengue  virus  serotype  combination
ccurring during  this  outbreak.  It has  been  pos-
ulated that  concurrent  infections  with  multiple
engue virus  serotypes  may  inﬂuence  the  clini-
al course  of  the  disease,  and  it  is  considered  as
he most  important  factor  in  the  emergence  of
HF.
During  the  dengue  outbreaks  of  1967,  1970
nd 1982  in  Delhi,  no  culture-conﬁrmed  cases  of
HF/DSS were  reported  [12,13,15,16].  However,
ome cases  of  DHF  were  observed  for  the  ﬁrst  time
n 1988  [17]. In  the  present  study,  17  cases  of  DHF
ere  observed;  6  had  single-serotype  infections,
nd 11  had  concurrent  infections.  Thus,  a  higher
ercentage  of  cases  with  concurrent  infections  had
evere disease.  However,  the  numbers  are  small,
nd larger  studies  are  needed  to  prove  this  associ-
tion.
The most  unusual  features  observed  in  this
eries were  encephalitis  and  a  higher  percentage
f ARDS,  whose  diagnoses  were  based  on  clinical
eatures  and  CSF  examination.  Dengue  infection
an cause  neurological  manifestations  ranging  from
on-speciﬁc  symptoms  to  encephalitis  and,  rarely,
uillain—Barré  syndrome.  The  virus  serotype  may
e involved,  but  DEN2  and  DEN3  are  most  frequently
eported as  the  cause  of  neurological  sequelae.  It  is
ikely that  we  observed  more  encephalitis  because
f the  prevalence  of  DEN2.  The  associations  of
ther unusual  features,  such  as  URI,  diarrhea,  jaun-
ice and  lymphadenopathy,  have  been  described  in
ther studies.
The seasonal  drift  of  dengue  virus  infection  is
evealed  by  the  maximum  positive  cases  observed
rom August  to  December,  which  is  in  agreement
ith previous  outbreaks  [19].  The  highest  number
f cases  positive  for  dengue  virus  by  RT-PCR  was
bserved  in  patients  less  than  10  years  (71.4%)  of
ge, as  shown  in  Table  1.
The most  challenging  problem  associated  with
atient  management  in  dengue  infection  is  rapid
iagnosis.  Although  the  commercially  available  MAC
LISAs or  ICT  offer  improvements  over  other  con-
entional  assays  for  diagnosis,  they  do  not  offer
erotype-speciﬁc  diagnosis.  Diagnosis  based  on  the
etection of the  NS1  antigen  can  be  achieved  on
Fpes  305
he  ﬁrst  day,  but  in  the  present  study,  NS1  was
ositive in  only  88.1%  of  cases,  and  IgM  antibod-
es were  only  detected  after  5—7  days  of  illness.
oncurrent infections  can  be  detected  by  virus
solation  in  tissue  culture  followed  by  indirect
mmunoﬂuorescence  using  serotype-speciﬁc  mon-
clonal antibodies  and/or  RT-PCR  [8]. However,
T-PCR offers  accuracy  and  speed  in addition  to
he serotype-speciﬁc  diagnosis  of  various  circu-
ating dengue  viruses  and  information  about  the
o-circulation  of  different  subtypes.  It  is now  clear
hat epidemics  caused  by  multiple  dengue  virus
erotypes  have  become  more  frequent  on  a global
asis  in  the  past  18  years  [6].  The  general  belief
s that  concurrent  infections  by  different  dengue
erotypes occur  during  epidemics  only,  where  mul-
iple virus  serotypes  are  being  transmitted.  The
o-circulation  of  multiple  dengue  serotypes  in  the
ame region  has  been  documented  in  several  coun-
ries for  decades  [12—14].
In this  outbreak,  the  detection  of  dengue  virus
NA by  RT-PCR  showed  that  DENV-2  and  DENV-3
ere the  most  common  etiologic  agents,  followed
y DENV-1  and  4.  All  four  dengue  virus  serotypes
ere found  to  co-circulate  in  the  current  out-
reak. In  Delhi  and  its  surrounding  areas,  only  two
oncurrent  dengue  cases  have  previously  been  iden-
iﬁed [18], but  the  number  has  now  signiﬁcantly
ncreased. The  occurrence  of  recombination  events
ay be  of extreme  importance  in  concurrent  infec-
ions  [19].  Viral  recombination  may  lead  to  the
mergence  of  more  virulent  strains.
onclusion
his  study  revealed  that  DENV-2  was  the  domi-
ant strain  in  this  outbreak,  even  though  all  four
erotypes  were  found  to  be  co-circulating  by  RT-
CR. The  increasing  trend  of  the  co-circulation  of
engue virus  serotypes  suggests  that  Davangere  dis-
rict is  becoming  an  endemic  area.  Although  the
ample size  in  this  study  was  small,  the  study  high-
ights the  high  percentage  of  concurrent  infections
ith  different  dengue  virus  serotypes  for  the  ﬁrst
ime in  India.
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